Overview:Nader Halim, PhD, Senior Director of Pfizer's External Science and Innovation team, will be offering office hours to meet with Researchers interested in applying for the Pfizer CTI Call for Preproposals as well as Researchers who would like feedback on proejcts within the CTI’s areas of interest. Meetings are available in 30 minute timeslots and can be booked here. If you are interested in submitting to the Pfizer CTI program or generally interested in feedback, we strongly encourage you to take advantage of this opportunity to speak with a Pfizer representative.
Bio: Nader Halim is a member of Pfizer’s External Science & Innovation (ES&I) team and is a scientific liaison to academic intuitions, biotechnology companies, and venture capital firms in New York City and the Mid-Atlantic region . Prior to his role in ES&I Nader was a member of Pfizer’s Global Policy Team where he focused on issues related to biologics, coding, coverage, and reimbursement. Prior to joining Pfizer Nader was a life science focused consultant where he lead teams and projects in multiple functional areas including market access, commercial, strategy and portfolio operations, health economics, and supply chain management. These projects spanned the life sciences spectrum including pharmaceuticals, healthcare based technology, medical devices, and diagnostics. He received his B.S. in biology from San Diego State University and a Ph.D. in molecular and cellular biology from the National Institutes of Health and the Uniformed Services University of the Health Sciences. He also completed his joint M.B.A and M.P.H. at Johns Hopkins University focused on the intersection of public health and healthcare.